iBio, Inc. IBIO

Set alert

Price alert · IBIO

All alert types
0.82 USD +0.02 +1.91%

As of Nov 3, 11:50 AM ET

Bid
0.82 × 2
Ask
0.82 × 2
0.7902 Day range 0.8359
0.69 52-week range 3.82
YTD
-57.76%
1 year
-53.68%
Open
0.80
Prev close
0.7999
Mkt cap
40.50M
Vol
83.81K
Avg vol
704.61K
EPS
-0.32
P/E
0.00
Div yield
0.00%
More statistics
Low
0.7902
High
0.8359
Forward P/E
-1.44
Beta
0.00
Short ratio
1.92
Inst. own
31.49%
Dividend
0.00
Ex-div date
Earnings
Feb 14, 2025
50-d avg
2.60
200-d avg
2.17
1y target
3.60

5D chart

Chart tools
Interval

Signals (138)
NameTimeAgo
RSI: OverboughtNov 3, 10:10 AM1 hour ago
RSI: OverboughtNov 3, 9:35 AM2 hours ago
SMA: BullishNov 2, 3:40 PM20 hours ago
SMA: BearishNov 2, 3:30 PM20 hours ago
SMA: BullishNov 2, 3:00 PM20 hours ago
SMA: BearishNov 2, 2:50 PM21 hours ago
SMA: BullishNov 2, 2:40 PM21 hours ago
SMA: BullishNov 2, 2:40 PM21 hours ago
MACD: Buy SignalNov 2, 2:40 PM21 hours ago
MACD: Sell SignalNov 2, 2:35 PM21 hours ago
SMA: BearishNov 2, 2:25 PM21 hours ago
SMA: BearishNov 2, 2:25 PM21 hours ago
SMA: BullishNov 2, 2:20 PM21 hours ago
SMA: BullishNov 2, 2:20 PM21 hours ago
SMA: BearishNov 2, 2:10 PM21 hours ago
SMA: BearishNov 2, 2:10 PM21 hours ago
SMA: BullishNov 2, 1:45 PM22 hours ago
MACD: Buy SignalNov 2, 1:45 PM22 hours ago
SMA: BullishNov 2, 1:35 PM22 hours ago
SMA: BearishNov 2, 1:30 PM22 hours ago

Newest 20 of 138.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 3.60
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy0
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 2
  • 2 months ago 2
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IBIO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.45-0.45 – -0.450.000.0%00.0%1
Next quarter-0.39-0.39 – -0.39-0.97899+60.2%00.0%1
Current year-1.74-1.74 – -1.74-4.29+59.5%0-100.0%1
Next year-2.05-2.05 – -2.05-1.74-17.8%00.0%1

Upgrades and downgrades

The latest rating changes

IBIO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024LUCID CAPITAL MARKETSInitiated—Buy
Jul 22, 2024Brookline CapitalInitiated—Buy
Jun 3, 2024Chardan CapitalMaintainedBuyBuy
May 28, 2024Chardan CapitalInitiated—Buy